Veterans Mental Illness Research Publications and Presentations | NW MIRECC - MIRECC / CoE
Attention A T users. To access the menus on this page please perform the following steps. 1. Please switch auto forms mode to off. 2. Hit enter to expand a main menu option (Health, Benefits, etc). 3. To enter and activate the submenu links, hit the down arrow. You will now be able to tab or arrow up or down through the submenu options to access/activate the submenu links.

MIRECC / CoE

Menu
Menu

Quick Links

Veterans Crisis Line Badge
My healthevet badge
EBenefits Badge
 

Veterans Mental Illness Research Publications and Presentations | NW MIRECC

NW Mental Illness Research, Education and Clinical Center's research on Veterans mental health including PTSD, TBI, addiction

2019 NW MIRECC Staff Publications and Presentations

Since the inception of the Veterans Affairs' Northwest Mental Illness Research, Education and Clinical Center, NW MIRECC has been heavily involved in research and the dissemination of their findings through lectures and article submissions.  The following is a sampling of publications and presentations from 2019 by VISN 20 NW MIRECC fellowship program faculty. Where available, a link to the full article is provided at the end of the summary. For a sampling of articles published prior to 2019, please see 2018, 2017, 2016, 2015, and 2014.

Kumthekar, A., Shull, S., Lovejoy, T. I., Morasco, B. J., Chang, M., & Barton, J. (2019). Impact of hepatitis C treatment on pain intensity, prescription opioid use and arthritisInternational Journal of Rheumatic Diseases22(4), 592-598.
A retrospective cohort study of Veterans with hepatitis C virus who were seen in a rheumatology clinic at least once while receiving direct acting anti‐viral (DAA) therapy between January 1, 2010 and December 31st 2016.  This research assessed the impact of direct acting anti‐viral (DAA) therapy for hepatitis C virus (HCV) infection on changes in pain intensity and prescription opioid use among Veterans.  Read full research article: Impact of hepatitis C treatment on pain intensity, prescription opioid use and arthritis

Leith, W. M., Lambert, W. E., Boehnlein, J. K., Freeman, M. D. (2019). The association between gabapentin and suicidality in bipolar patients. Int Clin Psychopharmacology 34:27-32.
The aims of this study were to assess the association between gabapentin and suicidality in patients diagnosed with bipolar disorder (BD) and to determine whether the risk is greater relative to patients prescribed lithium. Read full research article: The association between gabapentin and suicidality in bipolar patients

Morasco, B., Smith, N., Dobscha, S., Deyo, R., Hyde, S., & Yarborough, B. (2019). (142) Outcomes of prescription opioid dose escalation for the treatment of chronic pain: Results from a prospective cohort study. Journal of Pain, 20, S12.

Morasco, B. J., Krebs, E. E., Adams, M. H., Hyde, S., Zamudio, J., & Dobscha, S. K. (2019). Clinician response to aberrant urine drug test results of patients prescribed opioid therapy for chronic painClinical Journal of Pain35(1), 1-6.
Urine drug testing (UDT) is recommended for patients who are prescribed opioid medications, but little is known about the various strategies clinicians use to respond to abnormal urine drug testing results. We sought to examine changes in opioid prescribing and implementation of other risk reduction activities following an aberrant UDT. Read full research article: Clinician Response to Aberrant Urine Drug Test Results of Patients Prescribed Opioid Therapy for Chronic Pain

Seal, K. H., Borsari, B., Tighe, J., Cohen, B. E., Delucchi, K., Morasco, B. J., … Midboe, A. (2019). Optimizing pain treatment interventions (OPTI): A pilot randomized controlled trial of collaborative care to improve chronic pain management and opioid safety—rationale, methods, and lessons learnedContemporary Clinical Trials77, 76–85.
Veterans seeking care in VA medical facilities have high rates of chronic pain, which often co-occur with mental health and substance use disorders, including prescription opioid misuse. The overall goal of the Optimizing Pain Treatment Interventions (OPTI) study was to pilot a 12-week Collaborative Care intervention to improve opioid safety, chronic pain disability, and use of non-pharmacological pain management strategies in veterans in VA primary care.  Read full research article: Optimizing pain treatment interventions (OPTI): A pilot randomized controlled trial of collaborative care to improve chronic pain management and opioid safety

Wyse, J. J., Ganzini, L., Dobscha, S. K., Krebs, E. E., & Morasco, B. J. (2019). Setting expectations, following orders, safety, and standardization: Clinicians' strategies to guide difficult conversations about opioid prescribing. Journal of General Internal Medicine. Advance online publication. doi: 10.1007/s11606-019-04983-y
Evidence has continued to accumulate regarding the potential risks of treating chronic pain with long-term opioid therapy. Clinical practice guidelines now encourage clinicians to implement practices designed to reduce opioid-related risks. Yet how clinicians implement these guidelines within the context of the patient encounter has received little attention. This secondary analysis aimed to identify and describe clinicians’ strategies for managing prescription opioid misuse and aberrant behaviors among patients prescribed long-term opioid therapy for chronic pain. Read full research article: Setting Expectations, Following Orders, Safety, and Standardization: Clinicians' Strategies to Guide Difficult Conversations About Opioid Prescribing


For additional articles, please see: 2019 | 2018 | 2017 | 2016 | 2015 | 2014